Targets and Methods to Improve Outpatient Antibiotic Prescribing for Pediatric Patients

Nicole M Poole1, Holly Frost2

  • 1Department of Pediatrics, Division of Pediatric Infectious Diseases and Epidemiology, University of Colorado School of Medicine, Children's Hospital Colorado, 13123 East 16th Avenue, Aurora, CO 80045, USA.

Insights

Antibiotics are frequently overprescribed for children with respiratory infections, leading to antibiotic resistance and adverse health effects. Reducing unnecessary antibiotic use in pediatric outpatient settings is a critical public health goal.

Area of Science:

  • Pediatric medicine
  • Public health
  • Infectious disease

Background:

  • Antibiotic overuse in children's outpatient care is a significant issue.
  • This practice is common for acute respiratory tract infections.
  • Consequences include antibiotic resistance, adverse drug events, and chronic inflammation.

Purpose of the Study:

  • To outline the scope of antibiotic prescribing for children in outpatient settings.
  • To identify key areas for intervention and improvement.
  • To present practical strategies for reducing unnecessary antibiotic prescriptions based on national guidelines.

Main Methods:

  • Analysis of antibiotic prescribing patterns in pediatric outpatient settings.
  • Identification of targets for intervention.
  • Application of national recommendations for improvement strategies.

Main Results:

  • The study details the significant burden of antibiotic overprescription in pediatric care.
  • Specific targets for reducing unnecessary prescriptions were identified.
  • Pragmatic methods for measuring and improving prescribing were outlined.

Conclusions:

  • Decreasing unnecessary antibiotic use in children is a crucial public health priority.
  • The article provides a framework for addressing antibiotic stewardship in pediatric outpatient settings.
  • Implementing evidence-based strategies can mitigate the negative impacts of antibiotic overuse.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
8
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
60
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
19
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
64
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
9